{"version":"1.0","type":"link","title":"Immune-Related Adverse Events Among Patients With Endometrial Cancer Receiving Pembrolizumab Alone or With Other Treatments: A Single-Center Real-World Experience.","author_name":"Boyles G 외","author_url":"https://prs-insight.online/author/Boyles%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167534","thumbnail_width":1200,"thumbnail_height":630}